- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Erschienen in
-
In: Journal of Perinatal Medicine - Official Journal of the WAPM, Band 17, Ausgabe 2, Seite 107-111, 2009
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Humboldt-Universität zu Berlin
- (wann)
-
1989
- Urheber
-
Koelbl, Heinz
Kirchheimer, Johannes
Tatra, Gerhart
- DOI
-
10.1515/jpme.1989.17.2.107
- URN
-
urn:nbn:de:kobv:11-100116973
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koelbl, Heinz
- Kirchheimer, Johannes
- Tatra, Gerhart
- Humboldt-Universität zu Berlin
Entstanden
- 1989
Ähnliche Objekte (12)
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
The role of plasminogen activator inhibitor-2 in pneumococcal meningitis
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Alleviating Recombinant Tissue Plasminogen Activator‐induced Hemorrhagic Transformation in Ischemic Stroke via Targeted Delivery of a Ferroptosis Inhibitor
Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
The role of plasminogen activator inhibitor-2 in pneumococcal meningitis
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Alleviating Recombinant Tissue Plasminogen Activator‐induced Hemorrhagic Transformation in Ischemic Stroke via Targeted Delivery of a Ferroptosis Inhibitor
Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
The role of plasminogen activator inhibitor-2 in pneumococcal meningitis
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Alleviating Recombinant Tissue Plasminogen Activator‐induced Hemorrhagic Transformation in Ischemic Stroke via Targeted Delivery of a Ferroptosis Inhibitor